Possibilities and Limitations of Different Separation Techniques for the Analysis of the Protein Corona.
暂无分享,去创建一个
[1] Bing Yan,et al. Analytical strategies for detecting nanoparticle-protein interactions. , 2010, The Analyst.
[2] K. Landfester,et al. Complementary analysis of the hard and soft protein corona: sample preparation critically effects corona composition. , 2015, Nanoscale.
[3] Sara Linse,et al. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. , 2007, Angewandte Chemie.
[4] B. Ruozi,et al. Protein corona and nanoparticles: how can we investigate on? , 2017, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[5] G. Nienhaus,et al. The protein corona on nanoparticles as viewed from a nanoparticle-sizing perspective. , 2018, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[6] Andrzej S Pitek,et al. Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona. , 2012, ACS nano.
[7] Stefan Tenzer,et al. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. , 2011, ACS nano.
[8] A. Siripinyanond,et al. Investigation of silver nanoparticles and plasma protein association using flow field-flow fractionation coupled with inductively coupled plasma mass spectrometry (FlFFF-ICP-MS) , 2015 .
[9] Iseult Lynch,et al. What the cell "sees" in bionanoscience. , 2010, Journal of the American Chemical Society.
[10] O. Krichevsky,et al. Fluorescence correlation spectroscopy: the technique and its applications , 2002 .
[11] Joachim O Rädler,et al. Understanding the Kinetics of Protein–Nanoparticle Corona Formation , 2016, ACS nano.
[12] J. Veuthey,et al. Current possibilities of liquid chromatography for the characterization of antibody‐drug conjugates , 2018, Journal of pharmaceutical and biomedical analysis.
[13] W. Parak,et al. Techniques for the experimental investigation of the protein corona. , 2017, Current opinion in biotechnology.
[14] F. Benetti,et al. Hydrodynamic chromatography coupled to single-particle ICP-MS for the simultaneous characterization of AgNPs and determination of dissolved Ag in plasma and blood of burn patients , 2016, Analytical and Bioanalytical Chemistry.
[15] A. Timerbaev,et al. The fate of differently functionalized gold nanorods in human serum: A response from capillary electrophoresis-inductively coupled plasma mass spectrometry. , 2017, Journal of chromatography. A.
[16] G. Nienhaus,et al. In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy. , 2017, Accounts of chemical research.
[17] Seungpyo Hong,et al. Biomolecular corona on nanoparticles: a survey of recent literature and its implications in targeted drug delivery , 2014, Front. Chem..
[18] K. Landfester,et al. Pre-coating with protein fractions inhibits nano-carrier aggregation in human blood plasma , 2016 .
[19] A. Thünemann,et al. Characterization of Silver Nanoparticles in Cell Culture Medium Containing Fetal Bovine Serum. , 2015, Langmuir : the ACS journal of surfaces and colloids.
[20] Muhammad Imran Malik,et al. Field-flow fractionation: New and exciting perspectives in polymer analysis , 2016 .
[21] Kenneth A. Dawson,et al. Transferrin Coated Nanoparticles: Study of the Bionano Interface in Human Plasma , 2012, PloS one.
[22] Wenwan Zhong,et al. Dissociation-based screening of nanoparticle-protein interaction via flow field-flow fractionation. , 2013, Analytical chemistry.
[23] Richard R Burgess,et al. A brief practical review of size exclusion chromatography: Rules of thumb, limitations, and troubleshooting. , 2018, Protein expression and purification.
[24] Karl Fischer,et al. Evaluation of nanoparticle aggregation in human blood serum. , 2010, Biomacromolecules.
[25] Kenneth A. Dawson,et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.
[26] Harald Pasch,et al. An overview on field-flow fractionation techniques and their applications in the separation and characterization of polymers , 2009 .
[27] A. Timerbaev,et al. Speciation of metal-based nanomaterials in human serum characterized by capillary electrophoresis coupled to ICP-MS: a case study of gold nanoparticles. , 2015, Metallomics : integrated biometal science.
[28] Stefan Tenzer,et al. Aggregation Behavior of Polystyrene-Nanoparticles in Human Blood Serum and its Impact on the in vivo Distribution in Mice , 2014 .
[29] Andrew J Chetwynd,et al. Current Application of Capillary Electrophoresis in Nanomaterial Characterisation and Its Potential to Characterise the Protein and Small Molecule Corona , 2018, Nanomaterials.
[30] S. Molander,et al. Core–Shell Nanoplasmonic Sensing for Characterization of Biocorona Formation and Nanoparticle Surface Interactions , 2016 .
[31] De-Hao Tsai,et al. Adsorption and conformation of serum albumin protein on gold nanoparticles investigated using dimensional measurements and in situ spectroscopic methods. , 2011, Langmuir : the ACS journal of surfaces and colloids.
[32] J. Vallée,et al. Ex situ evaluation of the composition of protein corona of intravenously injected superparamagnetic nanoparticles in rats. , 2014, Nanoscale.
[33] Delyan R. Hristov,et al. Identification of Receptor Binding to the Biomolecular Corona of Nanoparticles. , 2017, ACS nano.
[34] Christoph Alexiou,et al. Magnetic nanoparticles as bimodal tools in magnetically induced labelling and magnetic heating of tumour cells: an in vitro study , 2007 .
[35] K. Landfester,et al. Preservation of the soft protein corona in distinct flow allows identification of weakly bound proteins. , 2018, Acta biomaterialia.
[36] G. Massolini,et al. Advances on Size Exclusion Chromatography and Applications on the Analysis of Protein Biopharmaceuticals and Protein Aggregates: A Mini Review , 2017, Chromatographia.
[37] Wenwan Zhong,et al. Size and Surface Functionalization of Iron Oxide Nanoparticles Influence the Composition and Dynamic Nature of Their Protein Corona , 2014, ACS applied materials & interfaces.
[38] W. Parak,et al. In situ detection of the protein corona in complex environments , 2017, Nature Communications.
[39] J. Klein. Probing the interactions of proteins and nanoparticles , 2007, Proceedings of the National Academy of Sciences.
[40] I. G. Márián,et al. Efficiency of magnetic hyperthermia in the presence of rotating and static fields , 2017, Journal of Magnetism and Magnetic Materials.
[41] R. Frost,et al. Real-time in situ analysis of biocorona formation and evolution on silica nanoparticles in defined and complex biological environments. , 2017, Nanoscale.
[42] Seraphine V. Wegner,et al. Engineering von Proteinen an Oberflächen: Von komplementärer Charakterisierung zu Materialoberflächen mit maßgeschneiderten Funktionen , 2018, Angewandte Chemie.
[43] A. Striegel,et al. Hydrodynamic chromatography of latex blends. , 2010, Journal of separation science.
[44] Claus-Michael Lehr,et al. Proteomic and Lipidomic Analysis of Nanoparticle Corona upon Contact with Lung Surfactant Reveals Differences in Protein, but Not Lipid Composition. , 2015, ACS nano.
[45] Ryosuke Ogaki,et al. Spatial mapping and quantification of soft and hard protein coronas at silver nanocubes. , 2014, Nano letters.
[46] R. Wu,et al. A nano-bio interfacial protein corona on silica nanoparticle. , 2018, Colloids and surfaces. B, Biointerfaces.
[47] A. Varenne,et al. Electromigration separation methodologies for the characterization of nanoparticles and the evaluation of their behaviour in biological systems , 2016 .
[48] C. Bria,et al. Impact of asymmetrical flow field-flow fractionation on protein aggregates stability. , 2016, Journal of chromatography. A.
[49] Hyeran Noh,et al. Volumetric interpretation of protein adsorption: competition from mixtures and the Vroman effect. , 2007, Biomaterials.
[50] A. Timerbaev,et al. CE Separation and ICP-MS Detection of Gold Nanoparticles and Their Protein Conjugates , 2017, Chromatographia.
[51] D. Huhn,et al. Preclinical experiences with magnetic drug targeting: tolerance and efficacy. , 1996, Cancer research.
[52] Iseult Lynch,et al. The evolution of the protein corona around nanoparticles: a test study. , 2011, ACS nano.
[53] Hanfa Zou,et al. Nanoparticle size matters in the formation of plasma protein coronas on Fe3O4 nanoparticles. , 2014, Colloids and surfaces. B, Biointerfaces.
[54] R. Felix,et al. MRI after magnetic drug targeting in patients with advanced solid malignant tumors , 2004, European Radiology.
[55] Henry Havel,et al. Nanomedicines: From Bench to Bedside and Beyond , 2016, The AAPS Journal.
[56] Marco P Monopoli,et al. Biomolecular coronas provide the biological identity of nanosized materials. , 2012, Nature nanotechnology.
[57] Sara Linse,et al. Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.
[58] M. Mahmoudi,et al. Significance of surface charge and shell material of superparamagnetic iron oxide nanoparticle (SPION) based core/shell nanoparticles on the composition of the protein corona. , 2015, Biomaterials science.
[59] M. Maskos,et al. Tuning the Surface of Nanoparticles: Impact of Poly(2-ethyl-2-oxazoline) on Protein Adsorption in Serum and Cellular Uptake. , 2016, Macromolecular bioscience.
[60] Alfred Fahr,et al. Asymmetric flow field-flow fractionation in the field of nanomedicine. , 2014, Analytical chemistry.
[61] Warren C W Chan,et al. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. , 2012, Chemical Society reviews.
[62] M. Moniatte,et al. Methods of protein corona isolation for magnetic nanoparticles. , 2017, The Analyst.
[63] P Reichardt,et al. Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. , 1996, Cancer research.
[64] Mélanie Auffan,et al. Protein corona formation for nanomaterials and proteins of a similar size: hard or soft corona? , 2013, Nanoscale.
[65] P. Cullis,et al. Drug Delivery Systems: Entering the Mainstream , 2004, Science.
[66] Katharina Landfester,et al. Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers. , 2016, Nature nanotechnology.
[67] M. Bonn,et al. Engineering Proteins at Interfaces: From Complementary Characterization to Material Surfaces with Designed Functions , 2018, Angewandte Chemie.
[68] Yu Matsumoto,et al. Aggregation behavior of cationic nanohydrogel particles in human blood serum. , 2014, Biomacromolecules.
[69] Thomas Lang,et al. The surface properties of nanoparticles determine the agglomeration state and the size of the particles under physiological conditions , 2014, Beilstein journal of nanotechnology.
[70] Stefan Tenzer,et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. , 2013, Nature nanotechnology.
[71] Stefan Tenzer,et al. Quantitative profiling of the protein coronas that form around nanoparticles , 2014, Nature Protocols.
[72] G. Caracciolo,et al. Analytical Methods for Characterizing the Nanoparticle–Protein Corona , 2014, Chromatographia.
[73] K. Dawson,et al. In situ characterization of nanoparticle biomolecular interactions in complex biological media by flow cytometry , 2016, Nature Communications.